日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

贝伐珠单抗辅助治疗复发风险高的黑色素瘤患者:AVAST-M试验的生存分析

Corrie, P G; Marshall, A; Nathan, P D; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, C G; Marples, M; Danson, S J; Marshall, E; Houston, S J; Board, R E; Waterston, A M; Nobes, J P; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Patel, P M; Ottensmeier, C H; Farrugia, D; Humphreys, A; Eccles, B; Young, G; Barker, E O; Harman, C; Weiss, M; Myers, K A; Chhabra, A; Rodwell, S H; Dunn, J A; Middleton, M R; Nathan, Paul; Lorigan, Paul; Dziewulski, Peter; Holikova, Sonja; Panwar, Udaiveer; Tahir, Saad; Faust, Guy; Thomas, Anne; Corrie, Pippa; Sirohi, Bhawna; Kelly, Charles; Middleton, Mark; Marples, Maria; Danson, Sarah; Lester, James; Marshall, Ernest; Ajaz, Mazhar; Houston, Stephen; Board, Ruth; Eaton, David; Waterston, Ashita; Nobes, Jenny; Loo, Suat; Gray, Gill; Stubbings, Helen; Gore, Martin; Harries, Mark; Kumar, Satish; Goodman, Andrew; Dalgleish, Angus; Martin-Clavijo, Agustin; Marsden, Jerry; Westwell, Sarah; Casasola, Richard; Chao, David; Maraveyas, Anthony; Marshall, Ernest; Patel, Poulam; Ottensmeier, Christian; Farrugia, David; Humphreys, Alison; Eccles, Bryony; Dega, Renata; Herbert, Chris; Price, Christopher; Brunt, Murray; Scott-Brown, Martin; Hamilton, Joanna; Hayward, Richard Larry; Smyth, John; Woodings, Pamela; Nayak, Neena; Burrows, Lorna; Wolstenholme, Virginia; Wagstaff, John; Nicolson, Marianne; Wilson, Andrew; Barlow, Clare; Scrase, Christopher; Podd, Timothy; Gonzalez, Michael; Stewart, John; Highley, Martin; Wolstenholme, Virginia; Grumett, Simon; Goodman, Andrew; Talbot, Toby; Nathan, Kannon; Coltart, Robert; Gee, Bruce; Gore, Martin; Farrugia, David; Martin-Clavijo, Agustin; Marsden, Jerry; Price, Christopher; Farrugia, David; Nathan, Kannon; Coltart, Robert; Nathan, Kannon; Coltart, Robert

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

评估接受化疗(含或不含伊匹木单抗)的小细胞肺癌患者的神经元自身抗体

Hardy-Werbin, M; Arpí, O; Taus, A; Rocha, P; Joseph-Pietras, D; Nolan, L; Danson, S; Griffiths, R; Lopez-Botet, M; Rovira, A; Albanell, J; Ottensmeier, C H; Arriola, E

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.

对切除食管腺癌的免疫组织化学预后生物标志物进行系统评价和荟萃分析

McCormick Matthews L H, Noble F, Tod J, Jaynes E, Harris S, Primrose J N, Ottensmeier C, Thomas G J, Underwood T J

Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

体外 IFN-γ ELISPOT 检测无需血清:欧洲 CIMT 免疫指导计划不同方案的合作研究

Mander, A; Gouttefangeas, C; Ottensmeier, C; Welters, M J P; Low, L; van der Burg, S H; Britten, C M

Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients

对小细胞肺癌患者进行骨髓穿刺液免疫细胞化学评估以监测化疗反应

Pelosi, G; Pasini, F; Ottensmeier, C; Pavanel, F; Bresaola, E; Bonetti, A; Fraggetta, F; Terzi, A; Iannucci, A; Cetto, G L